Companies Dominating the Colorectal Cancer Treatment Landscape
- Genentech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly and Company
- F. Hoffman-La Roche AG
- Bristol Myers Squibb
- Sanofi
- Merck Sharp & Dohme Corp.
- Bayer AG
- Novartis AG
- Taiho Oncology, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of colorectal cancer treatment is assessed at USD 20.8 billion.
Colorectal Cancer Treatment Market size was valued at USD 20.08 billion in 2024 and is expected to reach USD 34.28 billion by 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is estimated to account for largest revenue share by 2037, owing to increasing awareness about colorectal cancer and need to develop innovative cancer treatment solutions in the region.
The major players in the market are Genentech, Inc., Eli Lilly and Company, F. Hoffman-La Roche AG, and Bristol Myers Squibb, among others.
